← Evidence map

ArticleScientific reports2026

Extracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics by downregulating the ECM1/NF-κB/TGFβ signaling pathway.

Kaumudi Pande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Extracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics by downregulating the ECM1/NF-κB/TGFβ signaling pathway. | Socratic